| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/10/2003 | US20030130356 Such as 5,46-dihydroxy-3,8,18,23,28,33,38,43,48-decaazapentacontane decahydrochloride; side effect reduction |
| 07/10/2003 | US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction |
| 07/10/2003 | US20030130340 Novel benzothiophene derivatives |
| 07/10/2003 | US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents |
| 07/10/2003 | US20030130335 Protein tyrosine phosphatases inhibitors |
| 07/10/2003 | US20030130333 Combination product and methods of use |
| 07/10/2003 | US20030130328 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/10/2003 | US20030130309 Antiinflammatory agents; rheumatic diseases |
| 07/10/2003 | US20030130299 Administering dosage of immunology response moderator |
| 07/10/2003 | US20030130296 FXR NR1H4 nuclear receptor binding compounds |
| 07/10/2003 | US20030130293 Detection defect in gene expression of hedgehog gene; diagnosis of cancer |
| 07/10/2003 | US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents |
| 07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
| 07/10/2003 | US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 07/10/2003 | US20030130285 Controlling cell differentiation, cell proliferation |
| 07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2003 | US20030130280 Analyzing, prevention blood phosphorylation |
| 07/10/2003 | US20030130276 Method of treating certain cancers using an estrogen agonist/antagonist |
| 07/10/2003 | US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130272 Topoisomerase inhibitor; viricides |
| 07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
| 07/10/2003 | US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 07/10/2003 | US20030130260 Aryl fused azapolycyclic compounds |
| 07/10/2003 | US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents |
| 07/10/2003 | US20030130252 Process for affecting neurologic progression |
| 07/10/2003 | US20030130250 Methods to mobilize progenitor/stem cells |
| 07/10/2003 | US20030130242 Administering hypocalcemic hydroxyvitamin d compound having ahydrocarbon moiety at the c-24 position as anticarcinogenic agent |
| 07/10/2003 | US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors |
| 07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |
| 07/10/2003 | US20030130210 Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic |
| 07/10/2003 | US20030130209 Method of treatment of myocardial infarction |
| 07/10/2003 | US20030130201 Mixture with ascorbic acid, proline and lysine |
| 07/10/2003 | US20030130184 Using protein from papilloma virus; genetic engineering |
| 07/10/2003 | US20030130180 Utilization of an aminopeptidase inhibitor |
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/10/2003 | US20030130121 Novel bacterial isolate and the preparation and use of its active metabolites |
| 07/10/2003 | US20030129749 Comprises isogeneic antigen presenting cells |
| 07/10/2003 | US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance |
| 07/10/2003 | US20030129706 Fhm, a novel member of the TNF ligand supergene family |
| 07/10/2003 | US20030129696 Polynucleotides and polypeptides encoding receptors |
| 07/10/2003 | US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/10/2003 | US20030129662 Use of vascular endothelial growth factor (VEGF) |
| 07/10/2003 | US20030129655 Nucleic acids encoding GTPase activating proteins |
| 07/10/2003 | US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity |
| 07/10/2003 | US20030129644 Used in gene therapy |
| 07/10/2003 | US20030129596 Chemical compounds |
| 07/10/2003 | US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents |
| 07/10/2003 | US20030129269 Extracts of cacao and cacao bean husk with inhibitory effects on carcinogenesis |
| 07/10/2003 | US20030129268 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dematology, in cosmetics and as food additive |
| 07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
| 07/10/2003 | US20030129206 Medicament for the immunotherapy of malignant tumours |
| 07/10/2003 | US20030129203 Rep proteins; fusion proteins; high throughput assay; gene therapy |
| 07/10/2003 | US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 07/10/2003 | US20030129193 Comprises antibody-coagulant constructs (coaguligands) for induction of (drug resistant) tumor thrombosis/necrosis |
| 07/10/2003 | US20030129190 FX activity in cells in cancer, inflammatory responses and diseases and in autoimmunity |
| 07/10/2003 | US20030129188 Peptide mimetics; catalytic antibodies such as aldolase, beta-lactamase, esterase, or amidase; for treatment of angiogenesis, bone metabolism disorders, inflammation, or cell growth disorders |
| 07/10/2003 | US20030129186 Compositions and methods for modulating blood-brain barrier transport |
| 07/10/2003 | US20030129175 Gene therapy; heterogeneity tissue transcription; antitumor agents |
| 07/10/2003 | US20030129166 Human circulating dendritic cell compositions and methods |
| 07/10/2003 | US20030129133 PACAP compositions and methods for tumor imaging and therapy |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | US20030127621 Kinesin motor modulators derived from the marine sponge adocia |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/10/2003 | CA2471910A1 Benzocyclodecane derivatives with antitumor activity |
| 07/10/2003 | CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | CA2471647A1 Antibody composition which specifically binds to cd20 |
| 07/10/2003 | CA2471645A1 Immunoconjugates useful for treatment of tumours |
| 07/10/2003 | CA2471385A1 Preventives/remedies for cancer |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471206A1 Individualized anti-cancer antibodies |
| 07/10/2003 | CA2470903A1 A system for stable expression of sirnas in mammalian cells |
| 07/10/2003 | CA2470781A1 Cystine-knot fold protein |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 07/10/2003 | CA2464937A1 Long chain fatty alcohol substituents in antineoplastic agents |
| 07/09/2003 | EP1325932A2 Anti-vegf antibodies |
| 07/09/2003 | EP1325930A1 Mammal prolactin variants |
| 07/09/2003 | EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/09/2003 | EP1325922A2 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
| 07/09/2003 | EP1325914A1 Tetrahydroquinoline compounds |
| 07/09/2003 | EP1325904A1 Novel aliphatic compounds, process for their preparation and their usage |
| 07/09/2003 | EP1325748A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 07/09/2003 | EP1325739A1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 07/09/2003 | EP1325341A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 07/09/2003 | EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 07/09/2003 | EP1325137A2 Truncated phosphodiesterase-7 polypeptides |
| 07/09/2003 | EP1325134A2 Method to alter sugar moieties |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 07/09/2003 | EP1325019A1 Antisense modulation of clusterin expression |
| 07/09/2003 | EP1325011A2 Methods and compounds for treating proliferative diseases |